Abstract
Real-time monitoring of biomarkers has important applications in immediately determining, for example, disease progress or therapeutic effects to clinical decisions in the fields of diagnosis, prognosis and therapy. However, technologies developed in this area require frequent sample drawings, unattended analysis in situ, secure online monitoring, and, above all, patient’s safety, so from this point of view are still in their infancy. Current research activity in the area has been restricted to the extent of monitoring physical signals while glucose is the only biomarker generally monitored in real-time. To realize the future of unattended analysis, our research group has investigated various immuno-analytical concepts that enable, in particular, repetitive measurements of target biomarkers in a continuous or semi-continuous manner. The key actors in these achievements were monoclonal antibodies with unique characteristics, raised in our group, that potentially allow for real-time monitoring of target disease markers from tiny ionic molecules to complex proteins. Furthermore, we have investigated surrogate elements (e.g. receptors and cytokines) that translate cellular response to measurable signals, enabling us to determine the functional properties of analytes. In this review, continuous and semi-continuous monitoring techniques of different markers for acute myocardial infarction are presented.
Similar content being viewed by others
References
Liu, C., Lei, T., Ino, K., Matsue, T., Tao, N. & Li, C.Z. Real-time monitoring biomarker expression of carcinoma cells by surface plasmon resonance biosensors. Chem. Commun.48, 10389–10391 (2012).
Shao, H., Chung, J., Balaj, L., Charest, A., Bigner, D.D., Carter, B.S., Hochberg, F.H. Breakefield, X.O., Weissleder, R. & Lee, H. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat. Med.18, 1835–1841 (2012).
Arroyo-Currás, N., Somerson, J., Vieira, P.A., Ploense, K.L., Kippin, T.E. & Plaxco, K.W. Real-time measurement of small molecules directly in awake, ambulatory animals. Proc. Natl. Acad. Sci. U. S. A.114, 645–650 (2017).
Patel, S., Park, H., Bonato, P., Chan, L. & Rodgers, M. A review of wearable sensors and systems with application in rehabilitation. J. NeuroEng. Rehabil.9, 21 (2012).
Girardin, C.M., Huot, C., Gonthier M. & Delvin, E. Continuous glucose monitoring: A review of biochemical perspectives and clinical use in type 1 diabetes. Clin. Biochem.42, 136–142 (2009).
Renard, E. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr. Opin. Pharmacol.2, 708–716 (2002).
Tucholski, K., Sokolowska, M., Tucholska, D., Kaminska, H. & Jarosz-Chobot, P. Assessment of optimal insulin administration timing for standard carbohydrates-rich meals using continuous glucose monitoring in children with type 1 diabetes: A cross-over randomized study. J. Diabetes Invest.10, 1237–1245 (2019).
Vashist, S.K. & Luong, J.H.T. Handbook of immunoassay technologies. 1st Edition, pp.1–18 (2018).
Puiu, M. & Bala, C. SPR and SPR imaging: Recent trends in developing nanodevices for detection and real-time monitoring of biomolecular events. Sensors16, 870 (2016).
Concepcion, J., Witte, K., Wartchow, C., Choo, S., Yao, D., Persson, H., Wei, J., Li, P., Heidecker, B., Ma, W., Varma, R., Zhao, L.-S., Perillat, D., Carricato, G., Recknor, M., Du, K., Ho, H., Ellis, T., Gamez, J., Howes, M., Phi-Wilson, J., Lockard, S., Zuk, R. & Tan H. Label-free detection of biomolecular interactions using biolayer interferometry for kinetic characterization. Comb. Chem. High Throughput Screening12, 791–800 (2009).
Wegner, K.D., Lindén, S., Jin, Z., Jennings, T.L., el Khoulati, R., van Bergen en Henegouwen, P.M.P. & Hildebrandt, N. Nanobodies and nanocrystals: Highly sensitive quantum dot-based homogeneous FRET immunoassay for serum-based EGFR detection. Small10, 734–740 (2014).
Ngoc Le, H.T., Kim, J., Park, J. & Cho, S. A review of electrical impedance characterization of cells for label-free and real-time assays. Biochip J.13, 295–305 (2019).
Karachaliou, N., Mayo-de-las-Casas, C., Molina-Vila, M.A. & Rosell, R. Real-time liquid biopsies become a reality in cancer treatment. Ann. Transl. Med.3, 36 (2015).
Kim, D.H., Seo, S.M., Paek, S.H., Lim, G.S. & Paek, S.H. Premature antibodies with rapid reaction kinetics and their characterization for diagnostic applications. Anal. Biochem.420, 54–60 (2012).
Kim, D.H., Cho, I.H., Park, J.N., Paek, S.H., Cho, H.M. & Paek, S.H. Semi-continuous, real-time monitoring of protein biomarker using a recyclable surface plasmon resonance sensor. Biosens. Bioelectron.88, 232–239 (2017).
Paek, S.H., Park, J.N., Kim, D.H., Kim, H.S., Ha, U.H., Seo, S.K. & Paek, S.H. Semi-continuous, label-free immunosensing approach for Ca2+-based conformation change of a calcium-binding protein. Analyst139, 3781–3789 (2014).
Paek, S.H., Cho, I.H., Seo, S.M., Kim, D.H. & Paek, S.H. Production of rapidly reversible antibody and its performance characterization as binder for continuous glucose monitoring. Analyst136, 4268–4276 (2011).
Paek, S.H., Cho, I.H., Kim, D.H. Jeon, J.W., Lim, G.S. & Paek, S.H. Label-free, needle-type biosensor for continuous glucose monitoring based on competitive binding. Biosens. Bioelectron.40, 38–44 (2013).
Seo, D., Paek, S.H., Oh, S., Seo, S. & Paek, S.H. A human serum-based enzyme-free continuous glucose monitoring technique using a needle-type bio-layer interference sensor. Sensors16, 1581 (2016).
Cho, H.K., Seo, S.M., Cho, I.H., Paek, S.H., Kim, D.H. & Paek, S.H. Minimum-step immuno-analysis based on continuous recycling of the capture antibody. Analyst136, 1374–1379 (2011).
Kim, D.H., Paek, S.H., Lim, G.S., Jeon, J.W. & Paek, S.H. Performance characteristics of monoclonal antibodies as recyclable binders to cardiac troponin I. Anal. Biochem.431, 11–18 (2012).
Kim, D.H., Seo, S.M., Cho, H.M., Hong, S.J., Lim, D.S. & Paek, S.H. Continuous immunosensing of myoglobin in human serum as potential companion diagnostics technique. Biosens. Bioelectron.62, 234–241 (2014).
Wang, J. Electrochemical glucose biosensors. Chem. Rev.108, 814–825 (2008).
Cho, I.H., Jeon, J.W., Paek, S.H., Kim, D.H., Shin, H.S., Ha, U.H., Seo, S.K. & Paek, S.H. Toll-like receptor-based immuno-analysis of pathogenic micro-organisms. Anal. Chem.84, 9713–9720 (2012).
Jeon, J.W., Cho, I.H., Ha, U.H., Seo, S.K. & Paek, S.H. Chemiluminometric immuno-analysis of innate immune response against repetitive bacterial stimulations for the same mammalian cells. Sci. Rep.4, 6011 (2014).
Jeon, J.W., Ha, U.H. & Paek, S.H. In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing. PLoS One9, e105212 (2014).
Seo, S.M., Jeon, J.W., Kim, T.Y. & Paek, S.H. An innate immune system-mimicking, real-time biosensing of infectious bacteria. Analyst140, 6061–6070 (2015).
Neumann, J.T., Sörensen, N.A., Ojeda, F., Renné, T., Schnabel, R.B., Zeller, T., Karakas, M., Blankenberg, S. & Westermann, D. Early diagnosis of acute myocardial infarction using high-sensitivity troponin I. PloS One12, e0174288 (2017).
Lindahl, B., Venge, P. & Wallentin, L. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS study group. Biochemicals markers of acute coronary syndromes. Coron. Artery Dis.6, 321–328 (1995).
Kontos, M.C., Anderson, F.P., Hanbury, C.M., Roberts, C.S., Miller, W.G. & Jesse, R.L. Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction. Am. J. Emerg. Med.15, 14–19 (1997).
Capes, S.E., Hunt, D., Malmberg, K. & Gerstein, H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet355, 773–778 (2000).
Ishihara, M. Acute hyperglycemia in patients with acute myocardial infarction. Circ. J.76, 563–571 (2012).
O’Regan, T.M., O’Riordan, L.J., Pravda, M., O’Sullivan, C.K. & Guilbault, G.G. Direct detection of myoglobin in whole blood using a disposable amperometric immunosensor. Anal. Chim. Acta460, 141–150 (2002).
Cox, M. An overview of continuous glucose monitoring systems. J. Pediatr. Health Care23, 344–347 (2009).
Green, S.F. in Cardiac Markers. edited by Wu, A.H.B. (Humana Press, Totowa, NJ) pp.143–157 (1998)
Gibler, W.B., Runyon, J.P., Levy, R.C., Sayre, M.R., Kacich, R., Hattemer, C.R., Hamilton, C., Gerlach, J.W. & Walsh, R.A. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann. Emerg. Med.25, 1–8 (1995).
Yoo, E.H. & Lee, S.Y. Glucose biosensors: An overview of use in clinical practice. Sensors10, 4558–4576 (2010).
Bright, F.V., Betts, T.A. & Litwiler, K.S. Regenerable fiber-optic-based immunosensor, Anal. Chem.62, 1065–1069 (1990).
Chiu, A.Y., Matthew, W.D. & Patterson, P.H. A monoclonal antibody that blocks the activity of a neurite regeneration-promoting factor: studies on the binding site and its localization in vivo. J. Cell Biol.103, 1383–1398 (1986).
Nguyen, H.H., Park, J., Kang, S. & Kim, M. Surface plasmon resonance: A versatile technique for biosensor applications. Sensors15, 10481–10510 (2015).
Kelly, K.L., Coronado, E., Zhao, L.L. & Schatz, G.C. The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J. Phys. Chem. B107, 668–677 (2003).
Lee, S. & Choi, I. Fabrication strategies of 3D plasmonic structures for SERS. Biochip J.13, 30–42 (2019).
Rycenga, M., Cobley, C.M., Zeng, J., Li, W., Moran, C.H., Zhang, Q., Qin, D. & Xia, Y. Controlling the synthesis and assembly of silver nanostructures for plasmonic applications. Chem. Rev.111, 3669–3712 (2011).
Lim, J., Cho, E., Lee, K., Choi, Y., Seo, Y., Jeon, H. & Choi, J. Current immunotherapy approaches for malignant melanoma. Biochip J.13, 105–114 (2019).
Lee, J.C., Kim, S.J., Hong, S. & Kim, Y.S. Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers. Exp. Mol. Med.51, 53 (2019).
Acknowledgements
This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT, Korea (Project number NRF-2019R1H1A2079962) and the Technology Innovation Program (Grant number 10064060) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kim, DH., Paek, SH., Choi, DY. et al. Real-time Monitoring of Biomarkers in Serum for Early Diagnosis of Target Disease. BioChip J 14, 2–17 (2020). https://doi.org/10.1007/s13206-020-4102-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-020-4102-x